Management of unresectable and recurrent intra-abdominal desmoid tumors treated with ultrasound-guided high-intensity focused ultrasound: A retrospective single-center study.

Journal: Medicine
Treatment Used: Ultrasound-Guided High-Intensity Focused Ultrasound (HIFU)
Number of Patients: 15
Published:
MediFind Summary

Summary: This study assessed the safety and effectiveness of ultrasound (US)-guided high-intensity focused ultrasound (HIFU) ablation for the treatment of patients with unresectable and recurrent intra-abdominal desmoid tumors.

Conclusion: In patients with unresectable and recurrent intra-abdominal desmoid tumors, treatment with ultrasound-guided high-intensity focused ultrasound ablation is effective.

Abstract

To assess the efficacy and safety of ultrasound (US)-guided high-intensity focused ultrasound (HIFU) ablation for treatment of unresectable and recurrent intra-abdominal desmoid tumors. From June 2014 to March 2020, 15 patients with consecutive unresectable and recurrent diseases that pathologically proven to be intra-abdominal desmoid tumors had undergone the treatment of US-guided HIFU ablation. All patients underwent contrast-enhanced magnetic resonance imaging before and after HIFU treatment. Nonperfused volume ratio was used to evaluate the effect of HIFU therapy. Intraprocedural and postprocedural adverse effects and complications are recorded to assess the safety of the therapy. Outcome of HIFU ablation has been investigated through serial contrast-enhanced imaging examinations during follow up. Out of 15 patients 14 of them have successfully completed the whole therapy, 1 patient is ineffective and gives up further treatment. The mean nonperfused volume ratio is 71.1% (95% confidence interval, 3% to 88.2%). During a mean follow up of 29 months (range from 8 to 61 months), the mean tumor volume was reduced by 59% (95% confidence interval, +49% to -100%). No tumor spreads along the treated area in all patients except one. Complications have occurred in 5 patients (33.3%), including bowel rupture (1 case), intra-abdominal abscess (1 case), slight injury to the femoral nerve (1 case), and bone injury (2 cases), the bowel rupture patient underwent surgery; the others have been cured during the follow up. US-guided HIFU ablation is an effective treatment modality for patients suffered from unresectable and recurrent intra-abdominal desmoid tumors.

Authors
Yongming Yang, Jian Zhang, Ying Pan
Relevant Conditions

Fibromatosis, Desmoid Tumor

Similar Latest Advances